
Academic Journal
Q1eClinicalMedicine
About eClinicalMedicine
eClinicalMedicine is a scholarly journal published by Elsevier Ltd. SCImago 2025 places it in Q1 with an SJR of 4.171 and an H-index of 118.
Its listed coverage is 2018-2026 and its research categories include Medicine (miscellaneous) (Q1). The 2025 dataset reports 692 documents and 19257 citations across the latest three-year reporting window.
eClinicalMedicine is a cutting-edge platform that stands at the forefront of innovation in the medical and healthcare industry. With a focus on providing digital solutions, this platform aims to streamline the complexities of clinical trials and medical research. By integrating technology with clinical expertise, eClinicalMedicine has transformed the way healthcare professionals approach medical trials, offering a wide range of tools and resources designed to improve efficiency, accuracy, and patient outcomes.
What is eClinicalMedicine?
eClinicalMedicine is an online platform designed to facilitate the smooth execution of clinical trials, research, and other medical studies. It offers a vast array of services, including data management, trial monitoring, and medical analysis, all under one roof. The goal of eClinicalMedicine is to make clinical research more efficient, accessible, and accurate by providing researchers and medical professionals with advanced technology solutions that enhance the entire research process.
Key Features of eClinicalMedicine
-
Real-Time Data Collection and Analysis
One of the most significant benefits of using eClinicalMedicine is its ability to provide real-time data collection and analysis. This feature ensures that researchers can monitor progress and make data-driven decisions without delays. With instantaneous access to data, clinicians can rapidly assess the effectiveness of treatments and adjust strategies as necessary. -
Advanced Trial Management
eClinicalMedicine simplifies the trial management process by offering tools for planning, execution, and monitoring. From patient recruitment to data integration, the platform streamlines every phase of a clinical trial. This results in reduced operational costs, fewer errors, and improved timelines, ensuring that trials are completed on schedule. -
Patient-Centric Approach
The platform emphasizes patient engagement by offering tools that prioritize patient well-being throughout the research process. eClinicalMedicine ensures that patient data is handled securely, and it provides easy-to-navigate interfaces for patients to participate in clinical trials and track their progress. This patient-first approach is key to the platform’s success and its commitment to improving patient outcomes. -
Collaboration and Communication
Effective communication is crucial for successful clinical trials. eClinicalMedicine fosters collaboration among researchers, clinicians, and medical institutions by providing integrated communication tools. This encourages seamless data sharing, efficient decision-making, and the ability to troubleshoot issues quickly, all while maintaining a high level of security and confidentiality. -
AI-Powered Insights
Leveraging artificial intelligence, eClinicalMedicine can provide predictive analytics and insights that can enhance clinical trial design. By analyzing past trials and patient data, AI algorithms can forecast potential outcomes, enabling more informed decision-making and better patient selection. This reduces risks and improves the overall success rate of clinical studies.
Benefits of eClinicalMedicine
-
Increased Efficiency: By digitizing and automating many of the traditional tasks involved in clinical research, eClinicalMedicine significantly reduces the time and effort required for conducting trials.
-
Cost Savings: With better trial management and fewer operational inefficiencies, eClinicalMedicine helps reduce the cost of clinical trials and medical research.
-
Improved Patient Safety: The platform’s advanced monitoring tools and real-time data analysis help identify potential issues early, which can improve patient safety and treatment outcomes.
-
Global Reach: eClinicalMedicine connects researchers and healthcare providers from across the globe, promoting collaboration and sharing of knowledge on a larger scale.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
eClinicalMedicine, a leading journal in the field of healthcare, is dedicated to exploring the intersection of clinical medicine and digital health technologies. The journal serves as a critical resource for professionals in healthcare, technology, and research by providing in-depth, peer-reviewed articles that showcase the latest innovations and advancements in eHealth, digital health tools, and clinical medicine practices.
Understanding the Scope of eClinicalMedicine
The scope of eClinicalMedicine revolves around improving healthcare delivery through digital transformation. With the rapid development of technologies such as artificial intelligence (AI), machine learning (ML), wearable devices, telemedicine, and data analytics, this journal aims to bridge the gap between technology and medicine, offering solutions that can optimize patient care, treatment outcomes, and medical research.
-
Digital Health Technologies and Innovations
eClinicalMedicine covers a wide range of topics related to digital health technologies. These include the development and implementation of AI and ML algorithms in diagnostics, predictive analytics, and decision-making. The integration of wearable devices that monitor patient vitals in real-time is another area of focus. These innovations are enhancing the personalization of care and enabling clinicians to make more informed decisions based on accurate, real-time data. -
Telemedicine and Remote Healthcare
Telemedicine has become a central theme in modern healthcare, especially post-pandemic. The journal explores how telemedicine platforms are reshaping the way healthcare providers interact with patients, offering remote consultations, virtual therapy, and follow-ups. eClinicalMedicine also emphasizes the impact of telehealth on reducing healthcare disparities, making healthcare more accessible to rural and underserved populations. -
Clinical Trials and Digital Data
eClinicalMedicine is pivotal in the exploration of digital clinical trials and the use of big data in medical research. By leveraging data from electronic health records (EHRs), genomic sequencing, and real-time monitoring, researchers can better understand disease progression, treatment efficacy, and patient outcomes. The journal provides critical insights into how digital tools are transforming clinical trial designs, making them more efficient, inclusive, and scalable. -
Patient-Centered Care and Digital Therapeutics
Patient-centered care is at the heart of eClinicalMedicine’s scope. The journal highlights digital therapeutics, which are software-based interventions designed to prevent, manage, or treat medical conditions. These solutions empower patients to take an active role in their health, offering self-management tools for chronic diseases such as diabetes, cardiovascular conditions, and mental health disorders. -
Healthcare Policy, Ethics, and Regulation
As digital health technologies continue to evolve, eClinicalMedicine also delves into the ethical, regulatory, and policy implications surrounding these innovations. Topics such as data privacy, cybersecurity, the regulation of health apps and devices, and the integration of digital tools into existing healthcare frameworks are explored in depth. The journal serves as a platform for discussing the challenges and solutions related to ensuring the safety and efficacy of digital health tools.
Recent Research Articles
Latest publications matched automatically by ISSN.
Steroid, thiamine, and ascorbic acid for comatose out-of-hospital cardiac arrest survivors (STAR): a randomised, placebo-controlled, phase 2 trial
Youn-Jung Kim, Byuk Sung Ko, Young-Il Roh, Hyo Jeong Kwon et al.
2026-10 · DOI: 10.1016/j.eclinm.2026.104191Impact of posttraumatic stress disorder on incident cardiovascular outcomes in women veterans: a retrospective longitudinal study
Ramin Ebrahimi, Paul A. Dennis, Carlos A. Alvarez, A. Laurie Shroyer et al.
2026-10 · DOI: 10.1016/j.eclinm.2026.104197Patient-centred and fit-for-purpose clinical trials in rare cancers: lessons from sarcomas for operationalising 2024 WHO Guidance and ICH E6(R3)
Ornella Gonzato, Denise Reinke, Roger Wilson, Bernd Kasper et al.
2026-10 · DOI: 10.1016/j.eclinm.2026.104192Identification, validation, and prediction of longitudinal recovery phenotypes in degenerative cervical myelopathy: analysis of prospective cohorts and a randomised controlled trial
Karlo M. Pedro, Mohammed Ali Alvi, Christopher Lozano, Vishwathsen Karthikeyan et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104162Integration of lipidomic and polygenic risk scores within contemporary clinical cardiovascular risk assessment pathways: a multi-cohort development and validation study
Aleksandar Dakic, Jingqin Wu, Tingting Wang, Thomas G. Meikle et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104159Clearance of Treponema pallidum from oral and anal sites after treatment of secondary syphilis: results from a multi-centre, prospective, cross-sectional study
Janet M. Towns, Janath A. Fernando, Rebecca Wigan, Marcelina Krysiak et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104153Artificial intelligence and machine learning in heart and lung transplantation
Gaurav Sharma, Vineet Kumar Kamal, Lauren K. Truby, Maryjane Farr et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104180Intergenerational contact and depressive symptoms in midlife and older adults: an analysis of six cohort studies across 33 countries
Ruijie Gong, Xinyi Liu, Yalu Zhang, Ming Wen et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104148Use of procalcitonin point-of-care testing to guide de-escalation of antibiotic therapy in adults with suspected bacterial sepsis in a tertiary hospital in Bangladesh: a randomised controlled open-label trial
Forhad Uddin Hasan Chowdhury, Rabiul Alam Md Erfan Uddin, Mohammad Ali, Pranay Kumar Dutta et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104171Corrigendum to “Electroacupuncture for knee osteoarthritis: a multicentre randomised controlled trial assessing symptomatic and structural efficacy”
Minghui Hang, Yubo Shao, Wang Lu, Xiaoyun Wang et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104161Efficacy and safety of tiotropium in partial and uncontrolled preschool asthma (TIPP): a phase III, multicentre, randomised, double-blind, placebo-controlled trial
Stefan Zielen, Nadine Wollscheid, Tanja Nickolay, Caroline Grimmel et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104172RAS/MAPK pathway modulation with simvastatin in children with Noonan syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
Thomas Edouard, Yline Capri, Alain Verloes, Cyril Amouroux et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104114Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort study
Cristina Mussini, Andrea Giacomelli, Giuseppe Lapadula, Antonio Di Biagio et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104150Sex inequality in disease burden attributable to smoking, secondhand smoke and chewing tobacco: A systematic analysis for the Global Burden of Disease Study 2023
Sheng Li, Zhe Xu, Brooks Morgan, Dun Li et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104149Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial
James Russell Pike, Alison R. Huang, Nicholas Reed, Michelle L. Arnold et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104164From airways to arteries: cardiovascular and kidney risk in chronic obstructive pulmonary disease
Inuk Tórsheim, Alexander G. Mathioudakis, Pradeesh Sivapalan
2026-09 · DOI: 10.1016/j.eclinm.2026.104165Second ipsilateral locoregional recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a cohort study
Monica Milano, Carmine Valenza, Nadia Bianco, Simona Manacorda et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104174Building a genomics-capable cancer workforce: a competency-based framework for education and training in precision oncology
Amanda Drury, Yosr Hamdi, Nicola Mulder, Jens Rueter et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104142Pancreatic enzymes and bile acids alone and in combination for acutely ill, severely malnourished children: a multi-country double-blind randomised placebo-controlled trial
Robert H.J. Bandsma, Mohammod Jobayer Chisti, Wieger P. Voskuijl, Moses M. Ngari et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104110The association of ADHD and ADHD medication with adherence to pharmacotherapy for type 2 diabetes: a population-based cohort study from seven countries
Yiling Zhou, Honghui Yao, Tian Xie, Malcolm B. Gillies et al.
2026-09 · DOI: 10.1016/j.eclinm.2026.104182Reviews
Community Reviews
Version History
April 21, 2025 at 1:00 pm
April 21, 2025